The Impact of Sphingosine Kinase-1 in Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSCC) has a high reoccurrence rate and an extremely low survival rate. There is limited availability of effective therapies to reduce the rate of recurrence, resulting in high morbidity and mortality of advanced cases. Late presentation, delay in detection of...
Main Authors: | Toshihiko Kawamori, Kayoko Iino, Yoshiko Shimizu, Hideki Furuya, Paulette M. Tamashiro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | http://www.mdpi.com/2218-273X/3/3/481 |
Similar Items
-
Sphingosine kinase 1 contributes to the metastatic potential of epithelial ovarian cancer to the adipocyte-rich niche
by: Chen Wang, et al.
Published: (2022-11-01) -
Deletion of sphingosine kinase 2 attenuates cigarette smoke-mediated chronic obstructive pulmonary disease-like symptoms by reducing lung inflammation
by: Yanhui Chen, et al.
Published: (2023-03-01) -
The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target
by: Samar Sami Alkafaas, et al.
Published: (2024-02-01) -
A Dansyl-Modified Sphingosine Kinase Inhibitor DPF-543 Enhanced De Novo Ceramide Generation
by: Maftuna Shamshiddinova, et al.
Published: (2021-08-01) -
Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543
by: Xueliang Yi, et al.
Published: (2023-07-01)